• Tekni-Plex Creates New Organizational Structure, Setting Foundation for Growth Strategy

    Wayne, PA, September 9, 2021 – Tekni-Plex has reorganized its business structure into two key market-focused divisions: Tekni-Plex Healthcare and Tekni-Plex Consumer Products.  

    The reorganization is part of an intensive, eight-month planning effort to evolve Tekni-Plex into an innovative partner leveraging proprietary material-science application knowledge to provide solutions that make the world healthier and more sustainable. 

  • Pack Expo Las Vegas: Marchesini Group presents a monobloc machine for counting and capping plus a processing solution for the American market.

     Las Vegas (Nevada) – Marchesini Group will be exhibiting at the Pack Expo Las Vegas trade fair (27-29 September) with the support of its American office, Marchesini Group USA, which was established in 1992 and has since become a well-known contact for the pharmaceutical, biotech and nutraceutical industries in the American, Canadian and Puerto Rican markets.

  • At INTERPHEX NYC, Stevanato Group to Demo Robotic Inspection Unit, Present Modular Assembly Solutions and Recent After-sales Expansion


    Company’s solutions offer streamlined management of complex projects, enabling pharmaceutical companies to rely on a single partner from visual inspection to palletizing. At the show, Stevanato Group also will focus on its recently enhanced after-sales services for the US market.

  • Mondi scores a hat trick at Austrian Green Packaging Star Awards

    Mondi, global leader in packaging and paper, has won three awards for sustainable packaging at the Austrian Green Packaging Star Awards.

    The annual Green Packaging Star Awards recognise environmentally-friendly packaging and recycling solutions, as well as packaging-related improvements in operational processes in production, logistics, and distribution. The award is presented by Kompack magazine and the Austrian Research Institute for Chemistry and Technology.

    The judges of these awards recognised the high standard of the following three Mondi products:

  • Rondo-Pak Upgrades Equipment Line Up by Investing in New Heidelberg Printing Press

    Company’s new Heidelberg Speedmaster XL 106 10 Color Perfector is part of a multi-phase machinery investment in response to rapid business growth due to increased demand for specialized packaging

  • The Deltalab Group opts for COVID19 swab packaging with an ULMA Packaging thermoforming machine


    The Deltalab Group, a leader in laboratory products developed for the sample extraction market, samples that are subsequently analysed and included in virus detection processes, including reagents, instruments and consumables, is a national and international benchmark, with more than 40 years of experience in manufacturing laboratory supplies. Based in Rubí (Barcelona), its premise is to always follow the highest quality standards, with a clear focus on R&D, as well as sustainability and economic efficiency criteria based on a policy of continuous research and investment. With a solid international presence in more than 125 countries and a network of over 900 distributors, the Catalan company employs 250 workers, who work in 4 shifts, 7 days a week.

    In the face of the national emergency situation, the Deltalab Group has focused all of its production capacity on product lines for taking samples and detecting Covid19, with the aim of increasing its production and managing a demand that has risen exponentially.

    For Covid19 swab packaging, the Deltalab Group has continued to place its trust in ULMA Packaging machines, choosing a new TFS 300 for hermetic packaging. The Group is also planning to incorporate a new production machine with flow Pack packaging in the near future, model FM 300, which will join its current range of machines, allowing it to increase its production rates.

    ULMA Packaging has offered the Deltalab Group a comprehensive solution, featuring thermoforming and Flow Pack machines, as well as an after-sales team and a local technical service, thus allowing us to reinforce the already close collaboration with the client and continue assisting them and supporting them in their growth and in the new market challenges they face.

  • Sidel adjusts equipment prices due to rising raw material costs

    The global pandemic has affected the packaging solution industry by leading to a significant price increase and shortage of raw materials and components used in packaging equipment. To compensate for the rising costs and continue to provide the highest quality solutions, Sidel is implementing a commodity-induced price adjustment on its equipment by an average of 5% effective September 6, 2021. Deficiency of raw materials and components may impact equipment delivery time as well.

  • Pfizer aims to offer new COVID vaccine packaging options that could increase accessibility and decrease wasted doses


    The change has the potential to increase the availability of vaccines in smaller, more rural areas and decrease the number of wasted doses. 

    So far, the Pfizer vaccine has been available in two packages: one with 450 doses and another with 1,170. But the vaccine's cold storage requirement limits where and for how long they can be kept, making it challenging for smaller facilities to store high quantities of the vaccine without wasting doses.

    The CDC document was not specific about what the new packaging would entail, but told partners to "stay tuned for more details." In a statement to CBS News, Pfizer confirmed it's working on smaller packing options. The CDC did not respond to a request for comment. 

    Dr. Marcus Plescia, chief medical officer for the Association of State and Territorial Officers, told CBS News that the change could allow shipments to go directly to doctor's offices. Currently, doses meant for locations without sufficient storage capabilities are often siphoned off from a larger facility where they're held to reduce waste. 

    On Wednesday, a CDC spokesperson said more than 14.5 million doses have been wasted so far, roughly 3.4% of all delivered doses. The spokesperson said vaccines delivered in multidose vials, like the COVID-19 vaccines, typically have a waste rate of 5-15%.

    Plescia said getting vaccines to medical care providers quickly "is one of the strongest evidence-based practices that there is" to overcome vaccine hesitancy. 

    "We've seen over and over again, people will go and talk to their doctor and they'll be determined they're not going to be vaccinated, then talk to their doctor and they change their mind," he said. "This is the place we feel like we can get a lot of people to change their mind who aren't going to change their mind with the public messaging we're doing and other things." 

    The potential for smaller packages comes as federal regulators are considering authorizing and recommending booster doses for large swaths of the population. Currently, an additional dose of either Pfizer or Moderna is already authorized for Americans who are immunocompromised. 

    Adriane Casalotti, government and public affairs chief for the National Association of County and City Health Officials, says the smaller packages could help more rural public health departments that struggled with logistics in the spring.

    "This certainly would provide more flexibility for those situations," she said. Casalotti also noted that this move is significant particularly because it applies to the Pfizer vaccine, which is currently the only vaccine authorized for children.

    In the document, the CDC also said that orders of Johnson & Johnson's one-dose vaccine are slated to resume this month. Shipments have been restricted for months after many states reported unused doses following a bumpy rollout of the vaccine. Plescia emphasized that the Johnson & Johnson vaccine still remains a safe and viable option, especially for vaccinating people in emergency rooms who may be harder to reach for a second dose. 

  • FLEXcon launches PHARMcal


    FLEXcon has launched PHARMcal, a line of track and trace portfolio featuring engineered films with robust adhesion and optimized liners for pharmaceutical labeling.

    The line reduces complexity with a simplified product offering organized by end-use application, making it easier for customers and specifiers to select appropriate products for their intended use. 

    The portfolio features six product families to meet the needs of specific application requirements, such as small or large diameter containers, cover-up applications, extreme storage conditions, tamper-evidence, and secondary blood bag labeling. 

    All products are available globally and feature some of the company’s most high-performing adhesives, with raw material components locked down to ensure consistent quality and performance.

    ‘This consolidated product portfolio covers all the bases,’ said Lori Bitar, product manager, healthcare at FLEXcon. ‘Moving forward, both label converters and material specifiers can rest assured that the product they choose is appropriate for their application and that quality and performance will be consistent whether they’re producing a vaccine label, clinical trial label, plasma label, or tamper-evident box closure.’

    All PHARMcal products have been tested for durability and performance. Custom testing in the company’s DAP-certified lab is available for testing against specific application requirements and competitive product analysis.

  • Berry Sets Its Sights on eHealth Innovatiosn

    The latest pharmaceutical packaging and devices are supporting the growing trend towards eHealth, according to leading global supplier Berry Healthcare.

    eHealth seeks to promote and facilitate health and wellbeing in people, and enhance carer practice, through the use of information management and information and communication technology (ICT).

  • Pages